Life is good at the local multiplex if you're a premium exhibitor.
Shares of IMAX
Revenue climbed 17% to $51.1 million, and that was with fewer installations of the sales-type leases that the company books as immediate revenue. Many of the screens going up these days are part of joint-venture agreements with exhibitors. These arrangements may not have the same kind of top-line pop initially, but it does allow IMAX to participate more actively in the box office receipts and related concession sales.
Reported earnings grew fivefold to $0.10 a share, but even adjusted earnings more than doubled.
Clearly there's a healthy appetite for consumers to pay up a few bucks more for premium screenings, and this bodes well for IMAX, as well as sound specialist Dolby
IMAX is worldwide hit, and many of the 100 new theater signings that were inked during the quarter are overseas. IMAX claims that international ticket sales per screen are trending 25% higher than domestic screens, and that's excluding the global impact of Avatar.
There is now a backlog of 257 screens for IMAX to install over the next few years, well ahead of the 163 screens that were in the pipeline a year ago.
This is where things get interesting. When you combine a fast-growing network of theaters, studios bending over backwards to make sure that their blockbusters get the IMAX treatment, and the huge revenue-sharing upside of the joint-venture deals, IMAX is staring at a pretty beefy future as long as theater patrons don't tire of the premium experiences.
IMAX isn't settling for what it's currently offering. IMAX recently joined nanotechnology incubator Harris & Harris
IMAX also is a partner with Sony
The payoff for these ventures is far away, but investors should be fine with waiting it out as the global presence of IMAX screenings grows with every passing quarter.
There's life after Avatar for IMAX, and it's apparently even greener.
IMAXhas been around for decades, but some folks still think it's just a fad. What do you think? Share your thoughts in the comment box below.